Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT00885326
Title N2007-02:Bevacizumab,Cyclophosphamide,and Zoledronic Acid in Patients W/ Recurrent or Refractory High-Risk Neuroblastoma
Recruitment Completed
Gender both
Phase Phase I
Variant Requirements No
Sponsors New Approaches to Neuroblastoma Therapy Consortium



Bevacizumab + Cyclophosphamide + Zoledronic acid

Age Groups: child | adult
Covered Countries USA | CAN

Facility Status City State Zip Country Details
Children's Hospital Los Angeles Los Angeles California 90027-0700 United States Details
Lucile Packard Children's Hospital at Stanford University Medical Center Palo Alto California 94304 United States Details
UCSF Helen Diller Family Comprehensive Cancer Center San Francisco California 94143 United States Details
Children's Healthcare of Atlanta Atlanta Georgia 30322 United States Details
University of Chicago Comer Children's Hospital Chicago Illinois 60637 United States Details
Children's Hospital Boston Boston Massachusetts 02115 United States Details
C.S Mott Children's Hospital Ann Arbor Michigan 48109 United States Details
Duke University Medical Center Durham North Carolina 27710 United States Details
Cincinnati Children's Hospital Medical Center Cincinnati Ohio 45229-3039 United States Details
Children's Hospital of Philadelphia Philadelphia Pennsylvania 19104-4318 United States Details
Cook Children's Medical Center - Fort Worth Fort Worth Texas 76104 United States Details
Texas Children's Cancer Center Houston Texas 77030-2399 United States Details
Children's Hospital and Regional Medical Center - Seattle Seattle Washington 98105 United States Details
Hospital for Sick Children Toronto Ontario M5G 1X8 Canada Details
CHU Sainte Justine Montreal Quebec H3T 1C5 Canada Details
*Shaded cells indicate that there was no data available from for the field